Rigaferon Therapeutics
Rigaferon will generate novel classes of small molecule biopharmaceuticals to trigger cellular interferon production pathways to treat Hepatitis C.
| Startup type: | Competition Entry |
| Stage: | Just An Idea |
| Publicity: | Open to speaking to journalists. |
| Location: | UCSF/SF Bay Area |
OUR NEWS
Rigaferon Therapeutics has no news yet.
THINGS WE NEED
The Rigaferon Therapeutics team hasn't posted any needs yet.
